Haematologica (Oct 2024)

Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and / or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile

Paul Richardson,
Myo Htut,
Emma Scott,
Claudia Paba Prada,
Ira Gupta

Affiliations

Paul Richardson: Dana-Farber Cancer Institute, Boston, MA
Myo Htut: City of Hope, Duarte, CA
Emma Scott: Oregon Health and Science University, Portland, OR
Claudia Paba Prada: Dana-Farber Cancer Institute, Boston, MA
Ira Gupta: Menarini Group, New York, NY

DOI: https://doi.org/10.3324/haematol.2024.285380
Journal volume & issue: Vol. 999, no. 1

Abstract

Not available.

Published in Haematologica

ISSN: 0390-6078 (Print); 1592-8721 (Online)
Publisher: Ferrata Storti Foundation
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.haematologica.org

About the journal